Cargando…
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Recent advances in neoantigen research have accelerated the development of tumor immunotherapies, including adoptive cell therapies (ACTs), cancer vaccines and antibody-based therapies, particularly for solid tumors. With the development of next-generation sequencing and bioinformatics technology, t...
Autores principales: | Li, Jiangping, Xiao, Zhiwen, Wang, Donghui, Jia, Lei, Nie, Shihong, Zeng, Xingda, Hu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466891/ https://www.ncbi.nlm.nih.gov/pubmed/37649123 http://dx.doi.org/10.1186/s12943-023-01844-5 |
Ejemplares similares
-
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
por: Zhou, Weijun, et al.
Publicado: (2022) -
Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
por: Richard, Guilhem, et al.
Publicado: (2021) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023) -
Neoantimon: a multifunctional R package for identification of tumor-specific neoantigens
por: Hasegawa, Takanori, et al.
Publicado: (2020) -
Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)